Increased tissue endothelin-1-like immunoreactivity in the internal mammary artery of patients with diabetes or hypercholesterolemia modulates the graft flow in the peri-operative period

European Journal of Cardio-thoracic Surgery

Volumn 14, Issue 4, 1998, Pages 367-372

  Göbel, Heike ^a   Ihling, Christian ^a   Dentz, Janine ^c   Schaefer, Hans E ^a   Zeiher, Andreas M ^b   Fraedrich, Gustav ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c Universitatsklinik fur Chirurgie Innsbruck   (Austria)

Author keywords

Diabetes mellitus; Endothelin 1; Hypercholesterolemia; Internal mammary artery; Vasospasm

Indexed keywords

ENDOTHELIN 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INTERNAL MAMMARY ARTERY; MALE; PRIORITY JOURNAL;

BIOPSY; COHORT STUDIES; CORONARY CIRCULATION; DIABETES MELLITUS, TYPE 2; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS; INTRAOPERATIVE COMPLICATIONS; MALE; MAMMARY ARTERIES; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0032191318     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(98)00193-6     Document Type: Article

References (37)

1. Barner H.B. Use of the internal thoracic artery: simple, complex, or with a backup? Ann Thorac Surg. 57:1994;8-9.
2. Loop F.D., Lytle B.W., Cosgrove D.M., Stewart R.W., Goormastic M., Williams G.W., Golding L.A., Gill C.C., Taylor P.C., Sheldon W.C., Proudfit W.L. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 314:1986;6.
3. Friesewinkel O., Harris L.J., Crooke G.A., LaMendola C.L., Grossi E.A., Baumann F.G., Esposito R.A. Effects of graded reductions in internal mammary bypass flow on left ventricular function. Ann Thorac Surg. 56:1993;1348-1350.
4. Kawsuji M., Tsujiguchi H., Tedorya T., Taki J., Iwa T. Evaluation of postoperative flow capacity of internal mammary artery. J Thorac Cardiovasc Surg. 99:1990;696-702.
5. Carrel T., Kujawski T., Zünd G., Schwitter J., Amann F.W., Gallino A., Bertel O., Jenni R., Turina M. The internal mammary artery malperfusion syndrome: incidence treatment and angiographic verification. Eur J Cardio-thorac Surg. 9:1995;190-197.
6. Navia D., Cosgrove D.M., Lytle B.W.et al. Is the internal thoracic artery the conduit of choice to replace a stentic vein graft? Ann Thorac Surg. 57:1994;40-44.
7. Nataf P., Hadjiisky P., Bourbon A., Peuchmaurd M., Leprince P., Regan M., Escolano S., Gandjbakch I. Morphometric and metabolic profile of the distal segment of the internal mammary artery: caution on its use for coronary anastomoses. Eur J Cardio-thorac Surg. 10:1996;965-970.
8. He G.W., Acuff T.E., Yang C.Q., Ryan W.H., Mack M.J. Middle and proximal sections of human internal mammary artery are not 'passive conduits'. J Thorac Cardiovasc Surg. 106:1993;106.
9. Tedoriya T., Kawasuji M., Sakakibara N., Ueyama K., Watanabe Y. Pressure characteristics in arterial grafts for coronary bypass surgery. Cardiovasc Surg. 3:1995;381-385.
10. Morris JJ, Smith LR, Jones RH, Glower DD, Morris PB, Muhlbaier LH, Reves JG, Rankin JS. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation 1991;84:III275-III284.
11. Lüscher TF, Tanner FC. Endothelial regulation of vascular tone and growth. Am J Hypertension 1993;6:283S-293S.
12. Hasegawa K., Fujiwara H., Doyama K., Inada T., Ohtani S., Fujiwara T., Hosoda K., Nakao K., Sasayama S. ET-1 selective receptor in the arterial intima of patients with hypertension. Hypertension. 23:1994;288-293.
13. Yanigasawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
14. Yang Z., Richard D., von Segesser L., Bauer E., Stulz P., Turina M., Lüscher T.F. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm? Circulation. 82:1990;188-195.
15. Ihling C., Göbel H.R., Lippoldt A., Wessels S., Paul M., Schaefer H.E., Zeiher A.M. Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1. J Pathol. 179:1996;303-308.
16. Lerman A., Edwards B.S., Halett J.W., Heublein D.M., Sandberg S.M., Burnett J.C. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 325:1991;997-1001.
17. Zeiher A.M., Ihling C., Pistorius K., Schächinger V., Schaefer H.E. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet. 344:1994;1405-1406.
18. Zeiher A.M., Goebel H.R., Schächinger V., Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: a clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation. 91:1995;941-947.
19. Dubin D., Pratt R.E., Cooke J.E., Dzau V.J. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol. 1:1989;150-154.
20. Hu R.M., Levin E.R., Pedram A., Frank H.J.L. Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes. 42:1993;351-358.
21. Oliver F.J., de la Rubia G., Feener E.P., Lee M.E., Loeken M.R., Shiba T., Quertermous T., King G.L. Stimulation of endothelin-1 expression by insulin in endothelial cells. J Biol Chem. 266:1991;23251-23256.
22. Yamauchi T., Ohnaka K., Takayanagi R., Umeda F., Nawata H. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine endothelial aortic cells. FEBS Letters. 267:1990;16-18.
23. Lerman A., Webster M.W.I., Chesebro J.H., Edwards W.D., Wie C.M., Fuster V., Burnett J.C. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation. 88:1993;2923-2928.
24. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 29:1981;577-580.
25. Schaefer HE. Methoden zur histologischen, zytologischen und zytochemischen Diagnostik von Blut und Knochenmark. In: Remmele W, ed. Pathologie Vol 1. Berlin, Heidelberg, New York, Tokyo: Springer, 1984;435-452.
26. Bacon C.R., Cary N.R.B., Davenport A.P. Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res. 79:1996;794-801.
27. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. Diabetes, blood lipids and the role of obesity in coronary heart disease risks for women. The Framingham Study. Ann Intern Med. 87:1977;393-397.
28. Stout R.W. Diabetes and atherosclerosis-the role of insulin. Diabetologia. 16:1979;141-150.
29. Frank H.J.L., Levin E.R., Hu R.M., Pedram A. Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology. 133:1993;1092-1097.
30. Vita J.A., Treasure C.B., Nabel E.G., McLenachan J.M., Fish R.D., Yeung A.C., Vekshtein V.I., Selwyn A.P., Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491-497.
31. Zeiher A.M., Drexler H., Saurbier H.B., Just H. Endothelium-mediated coronary blood flow modulations in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 92:1993;652-662.
32. Zeiher A.M., Drexler H., Wollschläger H., Just H. Modulation of coronary vasomotor tone. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 83:1991;391-401.
33. Heistad D.D., Armstrong M.L., Marcus M.L., Piegors D.J., Mark A.L. Augmented responses to vasoconstrictor stimuli in hypercholesterinemic and atherosclerotic monkeys. Circ Res. 54:1984;711-718.
34. Hirata Y., Takagi Y., Fukuda Y., Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis. 78:1989;225-228.
35. Galatius-Jensen S., Wroblewski H., Emmeluth C., Bie P., Haunso S., Kastrup J. Plasma endothelin in congestive heart failure: effect of the ACE inhibitor fosinopril. Cardiovasc Res. 32:1996;1148-1154.
36. Komuro I., Kurihara I., Sugiyama T., Takaku F., Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Letters. 238:1988;249-252.
37. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med. 314:1986;488-500.